Rational fusion design inspired by cell-penetrating peptide: SS31/S-14 G Humanin hybrid peptide with amplified multimodal efficacy and bio-permeability for the treatment of Alzheimer's diseaseASIAN JOURNAL OF PHARMACEUTICAL SCIENCESIF11.92024-08-010OA
Extending dual-targeting upper-limit in liposomal delivery of lithospermic acid B for Alzheimer's mitochondrial revitalizationJOURNAL OF CONTROLLED RELEASEIF11.52024-03-010PRE
Brain-neuron targeted nanoparticles for peptide synergy therapy at dual-target of Alzheimer's disease脑-神经元靶向纳米粒用于阿尔茨海默病双靶点肽协同治疗JOURNAL OF CONTROLLED RELEASEIF11.52023-03-0114PRE
A dual-ligand fusion peptide improves the brain-neuron targeting of nanocarriers in Alzheimer's disease mice双配体融合肽改善阿尔茨海默病小鼠中纳米载体的脑-神经元靶向JOURNAL OF CONTROLLED RELEASEIF11.52020-04-0154PREAI
The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's diseaseJOURNAL OF CONTROLLED RELEASEIF11.52014-10-0178PREAI
Odorranalectin-conjugated nanoparticles: Preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administrationJOURNAL OF CONTROLLED RELEASEIF11.52011-04-01201PREAI
Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluationsJOURNAL OF CONTROLLED RELEASEIF11.52009-02-01341PRE